144 related articles for article (PubMed ID: 33732322)
1. Functional inhibition of Oct leads to HNF4α upregulation.
Vollmar J; Kim YO; Marquardt JU; Galle PR; Schuppan D; Zimmermann T
Exp Ther Med; 2021 Apr; 21(4):349. PubMed ID: 33732322
[TBL] [Abstract][Full Text] [Related]
2. Deletion of organic cation transporter Oct3 promotes hepatic fibrosis via upregulation of TGFβ.
Vollmar J; Kim YO; Marquardt JU; Becker D; Galle PR; Schuppan D; Zimmermann T
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G195-G202. PubMed ID: 31241979
[TBL] [Abstract][Full Text] [Related]
3. Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.
Vollmar J; Lautem A; Closs E; Schuppan D; Kim YO; Grimm D; Marquardt JU; Fuchs P; Straub BK; Schad A; Gründemann D; Schattenberg JM; Gehrke N; Wörns MA; Baumgart J; Galle PR; Zimmermann T
Oncotarget; 2017 Dec; 8(70):115667-115680. PubMed ID: 29383190
[TBL] [Abstract][Full Text] [Related]
4. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes.
Rulcova A; Krausova L; Smutny T; Vrzal R; Dvorak Z; Jover R; Pavek P
Pharmacol Rep; 2013; 65(5):1322-35. PubMed ID: 24399729
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
Yue HY; Yin C; Hou JL; Zeng X; Chen YX; Zhong W; Hu PF; Deng X; Tan YX; Zhang JP; Ning BF; Shi J; Zhang X; Wang HY; Lin Y; Xie WF
Gut; 2010 Feb; 59(2):236-46. PubMed ID: 19671543
[TBL] [Abstract][Full Text] [Related]
8. HNF4α induced chemosensitivity to oxaliplatin and 5-FU mediated by OCT1 and CNT3 in renal cell carcinoma.
Hagos Y; Wegner W; Kuehne A; Floerl S; Marada VV; Burckhardt G; Henjakovic M
J Pharm Sci; 2014 Oct; 103(10):3326-34. PubMed ID: 25175346
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
[TBL] [Abstract][Full Text] [Related]
10. The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation.
Sartor C; Bachelot L; Godard C; Lager F; Renault G; Gonzalez FJ; Perret C; Gougelet A; Colnot S
Liver Int; 2019 Apr; 39(4):727-739. PubMed ID: 30721564
[TBL] [Abstract][Full Text] [Related]
11. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.
Visentin M; van Rosmalen BV; Hiller C; Bieze M; Hofstetter L; Verheij J; Kullak-Ublick GA; Koepsell H; Phoa SS; Tamai I; Bennink RJ; van Gulik TM; Stieger B
Drug Metab Dispos; 2017 Feb; 45(2):166-173. PubMed ID: 27903597
[TBL] [Abstract][Full Text] [Related]
12. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.
Schaeffeler E; Hellerbrand C; Nies AT; Winter S; Kruck S; Hofmann U; van der Kuip H; Zanger UM; Koepsell H; Schwab M
Genome Med; 2011 Dec; 3(12):82. PubMed ID: 22196450
[TBL] [Abstract][Full Text] [Related]
14. Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation.
Hyrsova L; Smutny T; Trejtnar F; Pavek P
Drug Metab Rev; 2016 May; 48(2):139-58. PubMed ID: 27278216
[TBL] [Abstract][Full Text] [Related]
15. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
Kwak BJ; Choi HJ; Kim OH; Kim KH; You YK; Lee TY; Ahn J; Kim SJ
J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
[TBL] [Abstract][Full Text] [Related]
16. The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for ("squelching") SRC-1 coactivator.
Hyrsova L; Smutny T; Carazo A; Moravcik S; Mandikova J; Trejtnar F; Gerbal-Chaloin S; Pavek P
Br J Pharmacol; 2016 May; 173(10):1703-15. PubMed ID: 26920453
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis.
Denk GU; Soroka CJ; Mennone A; Koepsell H; Beuers U; Boyer JL
Hepatology; 2004 May; 39(5):1382-9. PubMed ID: 15122767
[TBL] [Abstract][Full Text] [Related]
18. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
Yin C; Lin Y; Zhang X; Chen YX; Zeng X; Yue HY; Hou JL; Deng X; Zhang JP; Han ZG; Xie WF
Hepatology; 2008 Nov; 48(5):1528-39. PubMed ID: 18925631
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
Hayhurst GP; Lee YH; Lambert G; Ward JM; Gonzalez FJ
Mol Cell Biol; 2001 Feb; 21(4):1393-403. PubMed ID: 11158324
[TBL] [Abstract][Full Text] [Related]
20. Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice.
Zhao J; Adams A; Roberts B; O'Neil M; Vittal A; Schmitt T; Kumer S; Cox J; Li Z; Weinman SA; Tikhanovich I
Hepatology; 2018 Mar; 67(3):1109-1126. PubMed ID: 29023917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
